| Á¦Á¶»ç |
Á¦Ç°ÄÚµå |
Á¦Ç°¸í |
¿ë·® |
°¡°Ý (ºÎ°¡¼¼º°µµ) |
ºñ°í |
»ç¿ëÀڸŴº¾ó |
| µ¥ÀÌÅͰ¡ ¾ø½À´Ï´Ù |
Á¾¸Å or »èÁ¦µÈ Á¦Ç°ÀÔ´Ï´Ù. °í°´Áö¿øÀ¸·Î ¹®ÀÇ ÁÖ¼¼¿ä. (02-2081-2510)
Keyword : SARS-CoV-2,COVID-19,coronavirus,Äڷγª¹ÙÀÌ·¯½º,epidemic,COVID,ÄÚºñµå,Neutralization,Neutralizing antibody,SARS-CoV-2 inhibition,pseudovirus,pseudotyped Lentivirus,vaccine,vaccine development,¹é½Å°³¹ß,¹é½Å,Ä¡·áÁ¦,Ç×ü,Ç×üġ·áÁ¦,therapeutics,monoclonal antibody therapy,BSL-2